Progress toward the clinical application of patient-specific pluripotent stem cells
Evangelos Kiskinis(Northwestern University), Kevin Eggan(Broad Institute)
Cited by 332
Related Papers
ALS-implicated protein TDP-43 sustains levels of STMN2, a mediator of motor neuron growth and repair
|Nature Neuroscience|2019|673
Progress in Understanding and Treating SCN2A-Mediated Disorders
|Trends in Neurosciences|2018|339
Assessing the Safety of Human Pluripotent Stem Cells and Their Derivatives for Clinical Applications
|Stem Cell Reports|2017|137
Monitoring peripheral nerve degeneration in ALS by label-free stimulated Raman scattering imaging
|Nature Communications|2016|102